![Julian Gilbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julian Gilbert
Vorsitzender bei
NUFORMIX PLC
Vermögen: 56 216 $ am 30.06.2026
Profil
Julian Clive Gilbert was the founder of Sosei R&D Ltd. (founded in 2000, title: Commercial Director), Acacia Pharma Ltd. (founded in 2006, title: Chief Executive Officer), and Acacia Pharma Group Ltd. (founded in 2007, titled: Chief Executive Officer & Director).
Current jobs include Non-Executive Chairman at Nuformix Plc (since 2022), Chairman at River Biomedics B V I.O.
(since 2022), Director at Nuformix Technologies Ltd. (since 2022), Non-Executive Director at Exvastat Ltd., and Non-Executive Director at Monument Therapeutics Ltd. (since 2021).
Former jobs include Non-Executive Director at IOTA NanoSolutions Ltd., Manager-Business Development at Mundipharma International Ltd., Licensing Executive at BTG Ltd., Head-Formulation Development at Smith Kline & French Laboratories Ltd., and Head-Licensing at Chiroscience Ltd. Education includes undergraduate and doctorate degrees from The University of Nottingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUFORMIX PLC 0.9% | 11.11.2025 | 23’521’428 ( 0.9% ) | 56 216 $ | 30.06.2026 |
Aktive Positionen von Julian Gilbert
| Unternehmen | Position | Beginn |
|---|---|---|
| NUFORMIX PLC | Vorsitzender | 28.07.2022 |
Monument Therapeutics Ltd.
 Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system | Direktor/Vorstandsmitglied | 01.08.2021 |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Direktor/Vorstandsmitglied | - |
River Biomedics B V I.O.
 River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops human 3D in vitro 3D human heart tissue for pre-clinical drug testing | Vorsitzender | 01.03.2022 |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Julian Gilbert
| Unternehmen | Position | Ende |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Gründer | 31.07.2019 |
IOTA NanoSolutions Ltd.
 IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Direktor/Vorstandsmitglied | 10.10.2013 |
Smith Kline & French Laboratories Ltd.
 Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Corporate Officer/Principal | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Julian Gilbert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
IOTA NanoSolutions Ltd.
IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Process Industries |
Smith Kline & French Laboratories Ltd.
Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Chiroscience Ltd. | |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Health Technology |
Nuformix Plc
 Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
River Biomedics B V I.O.
River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops human 3D in vitro 3D human heart tissue for pre-clinical drug testing | Health Technology |
Monument Therapeutics Ltd.
Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system | Health Technology |
